We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+17.84%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.61B
AUM Growth
+$110M
Cap. Flow
-$613M
Cap. Flow %
-23.5%
Top 10 Hldgs %
41.68%
Holding
110
New
10
Increased
19
Reduced
25
Closed
16

Top Buys

Rank Stock Value
1
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$48.5M
2
ALEC icon
Alector
ALEC
+$37M
3
IMMU
Immunomedics Inc
IMMU
+$31.6M
4
AXGN icon
Axogen
AXGN
+$30.4M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$27.1M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$42.3M
2
VCEL icon
Vericel Corp
VCEL
+$37.3M
3
EHTH icon
eHealth
EHTH
+$35.1M
4
ASND icon
Ascendis Pharma A/S
ASND
+$31.6M
5
UHS icon
Universal Health Services
UHS
+$28M

Sector Composition

Rank Sector Weight
1 Healthcare 68.74%
2 Financials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWAV
51
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$10.4M 0.4%
+312,146
New +$10.4M
NVTA
52
DELISTED
Invitae Corporation
NVTA
$9.68M 0.37%
413,200
-274,862
-40% -$4.85M
ALLO icon
53
Allogene Therapeutics
ALLO
$618M
$9.45M 0.36%
326,797
– –
ARDX icon
54
Ardelyx
ARDX
$1.28B
$9.2M 0.35%
3,284,298
+321,376
+11% +$836K
PTCT icon
55
PTC Therapeutics
PTCT
$6.52B
$8.92M 0.34%
+237,000
New +$7.96M
SYBX
56
DELISTED
Synlogic
SYBX
$8.41M 0.32%
73,843
– –
RYTM icon
57
Rhythm Pharmaceuticals
RYTM
$7.31B
$7.98M 0.31%
291,005
– –
INSP icon
58
Inspire Medical Systems
INSP
$1.46B
$7.89M 0.3%
139,000
-261,781
-65% -$14.1M
ATNX
59
DELISTED
Athenex, Inc. Common Stock
ATNX
$7.62M 0.29%
31,093
+558
+2% +$136K
ALIM
60
DELISTED
Alimera Sciences
ALIM
$6.42M 0.25%
403,529
– –
PFNX
61
DELISTED
Pfenex Inc.
PFNX
$5.67M 0.22%
918,187
-151,327
-14% -$662K
SIOX
62
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$5.28M 0.2%
496,291
-753,709
-60% -$7.51M
RCKT icon
63
Rocket Pharmaceuticals
RCKT
$376M
$4.91M 0.19%
280,000
– –
NEOS
64
DELISTED
Neos Therapeutics, Inc
NEOS
$4.7M 0.18%
1,799,141
+568,874
+46% +$1.33M
MGTX icon
65
MeiraGTx Holdings
MGTX
$1.15B
$4.03M 0.15%
234,000
– –
SYRE icon
66
Spyre Therapeutics
SYRE
$8.7B
$4.03M 0.15%
+20,002
New +$4.17M
AVDL
67
DELISTED
Avadel Pharmaceuticals
AVDL
$3.92M 0.15%
2,722,241
– –
ITMR
68
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$3.65M 0.14%
+314,136
New +$3.88M
AAC
69
DELISTED
AAC Holdings
AAC
$3.56M 0.14%
1,936,027
– –
CNST
70
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$3.43M 0.13%
253,400
-382,443
-60% -$3.43M
ALPN
71
DELISTED
Alpine Immune Sciences Inc
ALPN
$3.26M 0.13%
475,450
– –
RVLP
72
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$3.05M 0.12%
846,048
-292,208
-26% -$2.15M
HARP
73
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.7M 0.1%
+28,500
New +$3.75M
STIM icon
74
Neuronetics
STIM
$113M
$2.42M 0.09%
159,000
– –
TNDM icon
75
Tandem Diabetes Care
TNDM
$1.17B
$2.25M 0.09%
35,500
-518,265
-94% -$27.2M
1 2
3
4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q1 2019 Portfolio in Review

As of Q1 2019, Deerfield Management held 110 positions worth $2.61B, up 4.4% from $2.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Deerfield Management withdrew a net $613M in Q1 2019, closing 16 positions and reducing 25 holdings. Its most notable exit was Allergan plc, an estimated $24.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 70% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Alector worth $36.6M.

  • Deerfield Management's largest Q1 2019 buy was Alector: 1,956,923 shares worth $36.6M.
  • Deerfield Management added most to DIPLOMAT PHARMACY, INC. in Q1 2019, an estimated $48.5M increase.
  • Deerfield Management's biggest Q1 2019 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $42.3M.
  • Deerfield Management fully exited Allergan plc in Q1 2019, selling an estimated $24.1M.
  • Deerfield Management's ten largest holdings make up 42% of its $2.61B portfolio in Q1 2019.
  • Deerfield Management opened 10 new positions and closed 16 in Q1 2019.
  • Deerfield Management's portfolio value rose 4.4% quarter-over-quarter to $2.61B.

Based on Deerfield Management's 13F filing for Q1 2019, filed 15 May 2019.